Top Markets
Coin of the day
Noile-Immune Biotech Inc. Noile-Immune Biotech Inc.

Noile-Immune Biotech Inc.

4893
Rank in Stocks #26562
Established in 2015 and based in Minato, Japan, this company is dedicated to... Established in 2015 and based in Minato, Japan, this company is dedicated to exploring and advancing CAR-T cell technology for use in cancer immunotherapy treatments.
Share Price
$0.91341182
Market Cap
$39.55M
Change (1 day)
-0.71%
Change (1 year)
-26.05%
Country
JP
Trade Noile-Immune Biotech Inc. (4893)

Category

Revenue for Noile-Immune Biotech Inc. (4893)
Revenue in Aug 2026 TTM: 0
According to Noile-Immune Biotech Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Noile-Immune Biotech Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$12.62B -
US
$6.02B -
NL
$15.70B -
AU
$2.23B -
US
- -
CH